Insights

Gathering insights about IRIDEX…

Similar companies to IRIDEX

IRIDEX Tech Stack

Media & News

Zacks Initiates Coverage of Iridex With Neutral Recommendation
Discover why Zacks initiated coverage of IRIX with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Learn how global sales momentum and stronger liquidity are balanced against margin pressures and dependency on a key distributor.
Jan 02, 2026 | www.zacks.com
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a recently published independent, retrospective study in Ophthalmology and Therapy. The study demonstrates that retreatment of transscleral laser treatment using MicroPulse® technology (MicroPulse TLT) can safely and effectively further reduce intraocular pressure (IOP) in patients with glaucoma.1
Dec 11, 2025 | www.globenewswire.com
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a newly published study in Translational Vision Science & Technology (TVST) examining the thermal dynamics of transscleral laser treatments for glaucoma.1
Dec 08, 2025 | www.globenewswire.com
Iridex to Present at the Sidoti Year-End Virtual Investor Conference
MOUNTAIN VIEW, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Sidoti Year-End Virtual Investor Conference.
Dec 05, 2025 | www.globenewswire.com
IRIDEX Corporation (IRIX) Q3 2025 Earnings Call Prepared Remarks Transcript
IRIDEX Corporation ( IRIX ) Q3 2025 Earnings Call November 11, 2025 5:00 PM EST Company Participants Patrick Mercer - CEO, President & Director Romeo Dizon - Chief Financial Officer Conference Call Participants Philip Taylor - Gilmartin Group LLC Presentation Operator Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Third Quarter 2025 IRIDEX Earnings Conference Call.
Nov 11, 2025 | seekingalpha.com
Iridex Reports Third Quarter 2025 Financial Results
MOUNTAIN VIEW, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the third quarter ended September 27, 2025.
Nov 11, 2025 | www.globenewswire.com
Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025
MOUNTAIN VIEW, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the third quarter 2025 and provide a business update after the close of trading on Tuesday, November 11, 2025.
Oct 28, 2025 | www.globenewswire.com

IRIDEX's Email Address Formats

IRIDEX uses at least 2 format(s):

IRIDEX Email Formats	Example	Percentage
FLast@iridex.com	JDoe@iridex.com	77%
Last@iridex.com	Doe@iridex.com	13%
FirstLast@iridex.com	JohnDoe@iridex.com	5%
First.Last@iridex.com	John.Doe@iridex.com	3%
FMiddleLast@iridex.com	JMichaelDoe@iridex.com	1%
First@iridex.com	John@iridex.com	1%
First.Last@iridexgroup.ro	John.Doe@iridexgroup.ro	100%

Frequently Asked Questions

What is IRIDEX's stock symbol?

IRIDEX is a publicly traded company; the company's stock symbol is IRIX.

What is IRIDEX's official website and social media links?

IRIDEX's official website is iridexgroup.ro and has social profiles on LinkedIn.

What is IRIDEX's SIC code NAICS code?

IRIDEX's SIC code is 8711 - Engineering Services NAICS code is 237 - Heavy and Civil Engineering Construction.

How many employees does IRIDEX have currently?

As of December 2025, IRIDEX has approximately 501 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: L. N.Chief Security Officer: A. S.Chief Financial Officer: F. A.. Explore IRIDEX's employee directory with LeadIQ.